Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval

Contraception ◽

10.1016/j.contraception.2003.09.005 ◽

2004 ◽

Vol 69 (1) ◽

pp. 3-7 ◽

Author(s):

Jennifer Smit ◽

Julia Botha ◽

Lynn McFadyen ◽

Mags Beksinska

Keyword(s):

Medroxyprogesterone Acetate ◽

Dosing Interval ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of dosing interval. Smit J, Botha J, McFadyen L, et al. Contraception 2004; 69: 3–7

Journal of Family Planning and Reproductive Health Care ◽

10.1783/1471189041261537 ◽

2004 ◽

Vol 30 (3) ◽

pp. 198-198

Author(s):

Judy Murty

Keyword(s):

Medroxyprogesterone Acetate ◽

Dosing Interval ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Author response for "Bone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1‐Infected Young Adults using Depot Medroxyprogesterone Acetate or Non‐Hormonal Contraceptives in Uganda"

10.1002/jbm4.10446/v2/response1 ◽

2020 ◽

Author(s):

Flavia Kiweewa Matovu ◽

Martin Nabwana ◽

Noah Kiwanuka ◽

Delia Scholes ◽

Esther Isingel ◽

...

Keyword(s):

Bone Mineral Density ◽

Young Adults ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Author Response ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate ◽

Download Full-text

Depot Medroxyprogesterone Acetate in Teens: A Risk for Bone Health?

10.1542/peds.106.5.1137 ◽

2000 ◽

Vol 106 (5) ◽

pp. 1137-1138 ◽

Author(s):

Laura K. Bachrach ◽

Tim Cundy ◽

Susan M. Ott

Keyword(s):

Medroxyprogesterone Acetate ◽

Bone Health ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.496155 ◽

2006 ◽

Author(s):

David Hubacher

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.486922 ◽

2006 ◽

Author(s):

Kate Curtis

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727748411.793536806 ◽

2017 ◽

Author(s):

Phillip Hay

Keyword(s):

Oral Contraceptives ◽

Medroxyprogesterone Acetate ◽

Vaginal Microbiome ◽

Combined Oral Contraceptives ◽

Depot Medroxyprogesterone Acetate

Download Full-text

A semi‐mechanistic pharmacokinetic model for depot medroxyprogesterone acetate and drug‐drug interactions with antiretroviral and antituberculosis treatment.

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2324 ◽

2021 ◽

Author(s):

Jose Francis ◽

Rosie Mngqibisa ◽

Helen McIlleron ◽

Michelle A Kendall ◽

Xingye Wu ◽

...

Keyword(s):

Drug Interactions ◽

Medroxyprogesterone Acetate ◽

Pharmacokinetic Model ◽

Depot Medroxyprogesterone Acetate ◽

Antituberculosis Treatment

Download Full-text

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial

EClinicalMedicine ◽

10.1016/j.eclinm.2021.100800 ◽

2021 ◽

Vol 34 ◽

pp. 100800

Author(s):

Mags Beksinska ◽

Rodal Issema ◽

Ivana Beesham ◽

Tharnija Lalbahadur ◽

Katherine Thomas ◽

...

Keyword(s):

Medroxyprogesterone Acetate ◽

Weight Change ◽

Intrauterine Device ◽

Depot Medroxyprogesterone Acetate ◽

Open Label Trial ◽

Copper Intrauterine Device

Download Full-text

A Randomized Controlled Trial of Estrogen Replacement Therapy in Long-Term Users of Depot Medroxyprogesterone Acetate

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2002-020874 ◽

2003 ◽

Vol 88 (1) ◽

pp. 78-81 ◽

Author(s):

Tim Cundy ◽

Ruth Ames ◽

Anne Horne ◽

Judy Clearwater ◽

Helen Roberts ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Replacement Therapy ◽

Medroxyprogesterone Acetate ◽

Estrogen Replacement Therapy ◽

Controlled Trial ◽

Estrogen Replacement ◽

Depot Medroxyprogesterone Acetate ◽

Randomized Controlled

Download Full-text

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception did not influence early discontinuation

EClinicalMedicine ◽

10.1016/j.eclinm.2021.100857 ◽

2021 ◽

Vol 34 ◽

pp. 100857

Author(s):

Luis Bahamondes

Keyword(s):

Medroxyprogesterone Acetate ◽

Weight Change ◽

Intrauterine Device ◽

Early Discontinuation ◽

Depot Medroxyprogesterone Acetate ◽

Copper Intrauterine Device

Download Full-text